Anest. intenziv. Med. 2025;36(5):328-335 | DOI: 10.36290/aim.2025.058

Year 2025 in review - Cardiovascular issues in intensive care and perioperative medicineReview Article

Pořízka M.1, Šoltés J.1, Pudil J.2, Horejsek J.1
1 Klinika anesteziologie, resuscitace a intenzivní medicíny 1. lékařské fakulty Univerzity Karlovy a Všeobecné fakultní nemocnice v Praze
2 II. interní klinika - klinika kardiologie a angiologie 1. lékařské fakulty Univerzity Karlovy a Všeobecné fakultní nemocnice v Praze

Year 2025 brought significant advances in the field of cardiovascular issues in intensive and perioperative medicine. Research has focused primarily on the individualization of circulatory support, optimization of perfusion targets, and more accurate risk assessment. In the treatment of circulatory shock, there is a prevailing trend toward physiologically oriented, personalized strategies emphasizing hemodynamic phenotypes and a balance between fluid therapy, vasopressors, and mechanical circulatory support. Evidence continues to grow for the selective use of advanced methods, including mechanical cardiac support and extracorporeal cardiopulmonary resuscitation. In perioperative medicine, the focus is shifting toward systematic assessment of functional capacity and biomarkers, which allow for more accurate prediction of cardiovascular risk without the need for routine testing. Pharmacologic research confirms the safety of targeted heart rate control in septic patients and explores new approaches to anticoagulation during mechanical circulatory support. Overall, current developments are moving toward more precise phenotyping, integration of modern monitoring techniques, and rational use of advanced therapies. Individualization of treatment and cost-effectiveness are becoming the core principles of modern cardiovascular care in intensive medicine.

Keywords: intensive care medicine, heart failure, circulatory shock, mechanical circulatory support, perioperative risk.

Received: October 29, 2025; Revised: October 29, 2025; Accepted: December 3, 2025; Prepublished online: December 19, 2025; Published: December 22, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pořízka M, Šoltés J, Pudil J, Horejsek J. Year 2025 in review - Cardiovascular issues in intensive care and perioperative medicine. Anest. intenziv. Med. 2025;36(5):328-335. doi: 10.36290/aim.2025.058.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 40 CZK (1.7 EUR)
    will be unlocked 22.12.2026

    References

    1. Endo A, Yatabe T, Kanemura T, Nishida K, Watanabe A, Nagano O, et al. Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial. Intensive Care Med. 2025;51(3):1-10. Go to original source...
    2. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063-e1143. Go to original source...
    3. Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370(17):1583-1593. Go to original source...
    4. Carayannopoulos KL, Fox E, El-Kersh K, Esquinas A, Michard F, Reardon CC, et al. Mean arterial pressure targets and patient-important outcomes in critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med. 2023;51(2):241-253. Go to original source...
    5. Yoshimoto H, Oshima T, Tanaka S, Fujii T, Fujino Y, Nakada T. Optimal target blood pressure in critically ill adult patients with vasodilatory shock: a systematic review and meta-analysis. Front Physiol. 2022;13:962670. Go to original source...
    6. Maiwall R, Jindal A, Wani ZA, Kumar A, Pamecha V, Kumar C, et al. A randomised-controlled trial (TARGET-C) of high vs. low target mean arterial pressure in patients with cirrhosis and septic shock. J Hepatol. 2023;79(2):349-361. Go to original source...
    7. Angriman F, Alhazzani W, Zampieri FG, Briel M, Bassi GL, Lamontagne F, et al. Blood pressure targets for adults with vasodilatory shock - an individual patient data meta-analysis. NEJM Evid. 2025;4(1):EVIDoa2400359. Go to original source...
    8. Panwar R, Zhou J, Han J, Williams L, Shehabi Y, Myburgh J, et al. Individualized blood pressure targets versus standard care among critically ill patients with shock: a pilot multicenter randomized controlled trial. J Intensive Care. 2025;13(1):29. Go to original source...
    9. Loubani OM, Green RS. A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care. 2015;30(3):653.e9-17. Go to original source...
    10. National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network. Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023;388(6):499-510. Go to original source...
    11. Munroe ES, Latham H, White J, Churilov L, Bagshaw SM, Finfer S, et al. Peripheral vasopressor use in early sepsis-induced hypotension. JAMA Netw Open. 2025;8(8):e2529148. Go to original source...
    12. Acheampong A, Vincent JL. A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care. 2015;19(1):251. Go to original source...
    13. Neyra JA, Li X, Canepa-Escaro F, Adams-Huet B, Toto RD, Yee J, et al. Cumulative fluid balance and mortality in septic patients with or without acute kidney injury and chronic kidney disease. Crit Care Med. 2016;44(10):1891-1900. Go to original source...
    14. Tian DH, Smyth C, Keijzers G, Peake SL, Udy AA, Harwood R, et al. Safety of peripheral administration of vasopressor medications: a systematic review. Emerg Med Australas. 2020;32(2):220-227. Go to original source...
    15. Lewis T, Merchan C, Altshuler D, Papadopoulos J. Safety of the peripheral administration of vasopressor agents. J Intensive Care Med. 2019;34(1):26-33. Go to original source...
    16. Ramanan M, Peake S, Eastwood G, Bellomo R, French C, Myburgh J, et al. A randomised, controlled, feasibility trial comparing vasopressors infused via peripheral cannula versus central venous access for critically ill adults: The VIPCA trial. Crit Care Resusc. 2025;27(2):100106. Go to original source...
    17. Kalimouttou A, Churilov L, Finfer S, Bagshaw SM, Myburgh J, Lamontagne F, et al. Optimal vasopressin initiation in septic shock: the OVISS reinforcement learning study. JAMA. 2025;333(19):1688-1698. Go to original source...
    18. McDonald R, Ahmed S, Lamontagne F, Bassi GL, Arabi YM, Finfer S, et al. The effects of vasopressor choice on renal outcomes in septic shock: a systematic review of randomised trials as a guide for future research. Crit Care. 2025;29(1):417. Go to original source...
    19. Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med. 2013;41(7):1774-1781. Go to original source...
    20. Sharif S, Wang J, El-Kersh K, Michard F, Esquinas AM, Arabi Y, et al. Critical care ultrasonography for volume management: a systematic review, meta-analysis, and trial sequential analysis of randomized trials. Crit Care Explor. 2025;7(5):e1261. Go to original source...
    21. Díaz-Gómez JL. Fluid tolerance, hemodynamic/organ congestion, or congestion cascade in the critically ill - a must-known evolving concept in 2022. Crit Care Explor. 2022;4(12):154071. Go to original source...
    22. Beaubien-Souligny W, Benkreira A, Robillard P, Bouabdallaoui N, Chassé M, Lamarche Y, et al. Quantifying systemic congestion with point-of-care ultrasound: development of the venous excess ultrasound grading system. Ultrasound J. 2020;12(1):16. Go to original source...
    23. Mulder MP, Smorenberg A, Touw HR, Elbers PW, Ince C, Juffermans NP, et al. Context-specific clinical applicability of the end-expiratory occlusion test to predict fluid responsiveness in mechanically ventilated patients: a systematic review and meta-analysis. Eur J Anaesthesiol. 2025;42(8):737-746. Go to original source...
    24. de Courson H, Lorne E, Guinot PG. Changes in dynamic arterial elastance induced by volume expansion and vasopressor in the operating room: a prospective bicentre study. Ann Intensive Care. 2019;9(1):117. Go to original source...
    25. Bar S, Tibirica E, Guerin L, Mazoit JX, Lehot JJ, Vignon P, et al. Dynamic arterial elastance measured by uncalibrated pulse contour analysis predicts arterial-pressure response to a decrease in norepinephrine. Br J Anaesth. 2018;121(3):534-540. Go to original source...
    26. Guinot PG, Lorne E, Bar S, Bernard E, Dupont H, Lebuffe G, et al. A norepinephrine weaning strategy using dynamic arterial elastance is associated with reduction of acute kidney injury in patients with vasoplegia after cardiac surgery: a post-hoc analysis of the randomized SNEAD study. J Clin Anesth. 2023;88:111124. Go to original source...
    27. Nagai Y, Takei T, Saito Y, Iizuka Y, Nishikimi M, Naito Y, et al. Real-world evaluation of Eadyn as a predictor of vasopressor weaning success in critically ill patients: a retrospective cohort study. Crit Care. 2025;29(1):350. Go to original source...
    28. Russo A, Ristagno G, Lazzeri C, Cecconi M, Giannini F, Guarracino F, et al. A dynamic elastance-based protocol to guide intra-operative fluid management in major abdominal surgery: a randomised clinical trial. Eur J Anaesthesiol. 2025;42(8):727-736. Go to original source...
    29. Arabi YM, Myburgh J, Lamontagne F, Rewa O, van der Horst ICC, Cecconi M, et al. European Society of Intensive Care Medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 1: the choice of resuscitation fluids. Intensive Care Med. 2024;50(6):813-831. Go to original source...
    30. Mekontso Dessap A, Cecconi M, Arabi YM, Myburgh J, Lamontagne F, Rewa O, et al. European Society of Intensive Care Medicine (ESICM) 2025 clinical practice guideline on fluid therapy in adult critically ill patients: part 2-the volume of resuscitation fluids. Intensive Care Med. 2025;51(3):461-477. Go to original source...
    31. Ostermann M, Myburgh J, Lamontagne F, Cecconi M, Arabi YM, Rewa O, et al. European Society of Intensive Care Medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 3 - fluid removal at de-escalation phase. Intensive Care Med. 2025;51(4):1-15. Go to original source...
    32. Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, et al. Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: 1-year outcomes of the multicentre, randomized ECMO-CS trial. Eur J Heart Fail. 2025;27(1):30-36. Go to original source...
    33. Lim Y, Kim MC, Jeong IS. Early left ventricular unloading during VA-ECMO: randomized controlled trial (EARLY-UNLOAD). Acute Crit Care. 2023;39(4):473-487. Go to original source...
    34. Lim Y, Kim MC, Jeong IS, et al. Early routine LV unloading during VA-ECMO did not improve 1-year outcomes: follow-up analysis of EARLY-UNLOAD. Acute Crit Care. 2025;41(1):55-64.
    35. Picado-Loaiza S, Ayala R, Ferreira RO, Zeledón F, Almeidinha L, Clemente M, et al. Early versus bail-out left ventricular unloading during veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2025;39:1015-1025. Go to original source...
    36. Lim Y, Kim MC, Jeong IS. Left ventricle unloading during veno-arterial extracorporeal membrane oxygenation: review with updated evidence. Acute Crit Care. 2024;39(4):473-487. Go to original source...
    37. Khiabani AJ, Pawale A. Extracorporeal membrane oxygenation in cardiogenic shock: execution is something; timing is everything. J Am Heart Assoc. 2024;13:e033348. Go to original source...
    38. Helms J, Frere C, Thiele T, Tanaka KA, Neal MD, Steiner ME, et al. Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2022;21:373-396. Go to original source...
    39. Šoltés J, Skribuckij M, Říha H, Lipš M, Michálek P, Balík M, et al. Update on anticoagulation strategies in patients with ECMO - a narrative review. J Clin Med. 2023;12(18):6067. Go to original source...
    40. Wieruszewski PM, Macielak SA, Nei SD, Moman RN, Seelhammer TG, Nabzdyk CGS, et al. Heparin versus bivalirudin for anticoagulation in adult extracorporeal membrane oxygenation: a systematic review and meta-analysis. ASAIO J. 2023;69(2):137-144. Go to original source...
    41. Kartika T, Mathews R, Migneco G, Bundy T, Kaempf AJ, Pfeffer M, et al. Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: heparin versus bivalirudin. Eur J Haematol. 2024;112(4):566-576. Go to original source...
    42. Kawauchi A, Okada Y, Aoki M, Inoue A, Hifumi T, Sakamoto T, et al. Clinical prediction score for patients with initial nonshockable rhythm receiving extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest: development and internal validation. J Am Heart Assoc. 2025;14(17):e042734. Go to original source...
    43. Miyamoto Y, Kitamura T, Zha L, Matsumoto M, Sato N, Tanaka H, et al. Left-digit bias in outcomes and invasive treatments among out-of-hospital cardiac arrest patients with shockable rhythm: a nationwide multicenter observational study with regression discontinuity design analysis. Crit Care. 2025;29:389. Go to original source...
    44. Koukousaki D, Kosmopoulos M, Sebastian P, Kalra R, Alexy T, Gutierrez A, et al. Effect of time to extracorporeal cardiopulmonary resuscitation on survival outcomes in in-hospital cardiac arrest patients. Resuscitation. 2025;110857. Go to original source...
    45. Ali S, Moors X, van Schuppen H, Mommers L, Weelink E, Meuwese CL, et al. A national multicentre pre-hospital ECPR stepped wedge study: design and rationale of the ON-SCENE study. Scand J Trauma Resusc Emerg Med. 2024;32(1):31. Go to original source...
    46. Singer B, Hla TTW, Abu-Habsa M, Davies G, Wrigley F, Faulkner M, et al. Sub30: feasibility study of pre-hospital extracorporeal membrane oxygenation in patients with refractory out-of-hospital cardiac arrest in London, United Kingdom. Resuscitation. 2025;207:110455. Go to original source...
    47. Kruit N, Burns B, Shearer N, Hui J, Coggins A, Buscher H, et al. Pre-hospital ECPR for refractory cardiac arrest - the PRECARE pilot feasibility study. Resuscitation. 2025;212:110631. Go to original source...
    48. Leroux L, Dennis-Benford NB, Bergeron A, Lamhaut L, Cournoyer A, Grunau B, et al. Impact of prehospital extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest on survival with good neurological function: a systematic review and meta-analysis. Resusc Plus. 2025;24:100974. Go to original source...
    49. Ling RR, Chen Y, Low CJW, Agerstrand C, Jung JS, Lim SL, et al. Left ventricular unloading during extracorporeal cardiopulmonary resuscitation: a target trial emulation of the ELSO registry. Crit Care. 2025;29(1):186. Go to original source...
    50. Malik J, Valerianova A, Janota T, Smalcova J, Kubinova N, Rob D, et al. Lower cholesterol level on admission predicts poor outcome after prolonged cardiac arrest. Sci Rep. 2025;15(1):20512. Go to original source...
    51. Pudil J, Leníček M, Kaválková P, Rob D, Dusík M, Tvrdoň J, et al. Higher bilirubin on admission predicts better outcome in refractory cardiac arrest: a Prague OHCA trial analysis focused on the antioxidant effect of bilirubin. Resusc Plus. 2025;25:101023. Go to original source...
    52. Havranek S, Neuhöfer J, Vesela M, Kavalkova P, Rob D, Fingrova Z, et al. Cardiac rhythm conversions and the outcome in refractory out-of-hospital cardiac arrest: extracorporeal versus conventional resuscitation. Crit Care Med. 2025;53(10):e1930-e1940. Go to original source...
    53. Farkasovska K, Rob D, Dacev M, Kavalkova P, Macoun J, Dusík M, et al. Reasons for death in patients receiving ECPR for refractory out-of-hospital cardiac arrest. Resuscitation. 2025;213:110615. Go to original source...
    54. Alenazi A, Alotaibi B, Madan J, Yeung J, Johnson S, Couper K, et al. The cost-effectiveness of extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest: a systematic review. Resuscitation. 2025;110822. Go to original source...
    55. Delnoij TSR, Suverein MM, Essers BAB, Hermanides RC, Otterspoor L, Elzo Kraemer CV, et al. Cost-effectiveness of extracorporeal cardiopulmonary resuscitation vs conventional cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a pre-planned, trial-based economic evaluation. Eur Heart J Acute Cardiovasc Care. 2024;13(6):484-492. Go to original source...
    56. Rehberg S, Frank S, Černý V, Cihlář R, Borgstedt R, Biancofiore G, et al. Landiolol for heart rate control in patients with septic shock and persistent tachycardia: a multicenter randomized clinical trial (Landi-SEP). Intensive Care Med. 2024;50(10):1622-1634. Go to original source...
    57. Hasegawa D, Sato R, Prasitlumkum N, Nishida K, Takahashi K, Yatabe T, et al. Effect of ultrashort-acting β-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a systematic review and meta-analysis of randomized controlled trials. Chest. 2021;159(6):2289-2300. Go to original source...
    58. Paneer Selvam S, Gamarra-Valverde NN, Tripoli A, Samaniego MA, Giorgi J. Efficacy and safety of landiolol in the treatment of tachycardia in patients with sepsis and septic shock: a systematic review and meta-analysis. Cureus. 2025;17(7):e88004. Go to original source...
    59. Bosch NA, Rucci JM, Massaro JM, Winter MR, Quinn EK, Chon KH, et al. Comparative effectiveness of heart rate control medications for the treatment of sepsis-associated atrial fibrillation. Chest. 2021;159(4):1452-1459. Go to original source...
    60. Huang G, Li H, Song F, Zhang C, Jian M, Huang C, et al. Intravenous beta-blockers versus amiodarone on in-hospital mortality and safety profile in adult septic patients. Med Intensiva (Engl Ed). 2025;49(7):502143. Go to original source...
    61. Birmingham Clinical Trials Unit. ABBRUPT: A trial of rate control in new-onset atrial fibrillation in ICU [online]. Birmingham (UK): University of Birmingham; [cit. 2025-10-16]. Dostupné z: https://www.birmingham.ac.uk/research/bctu/trials/portfolio-v/abbrupt.
    62. Thompson A, Fleischmann KE, Smilowitz NR, de las Fuentes L, Mukherjee D, Aggarwal NR, et al. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery. J Am Coll Cardiol. 2024;84(19):1869-1969. Go to original source...
    63. Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol. 2018;14(10):589-603.
    64. Giraud R, Siegenthaler N, Martin PY, Carteron L, Pugin J, Yamada T, et al. Acid-base disorders in critically ill patients: new insights into diagnosis and management. Intensive Care Med. 2021;47(1):27-38.
    65. Jaber S, Paugam-Burtz C, Dupres M, Baudin F, Rimmelé T, Mercier E, et al. Effect of sodium bicarbonate therapy on mortality in patients with severe metabolic acidosis and acute kidney injury: the BICAR-ICU randomized clinical trial. Lancet. 2018;392(10141):31-40. Go to original source...
    66. Peyton PJ, Bellomo R, Glassford NJ, Yeh YZ, Raman S, Caironi P, et al. Sodium bicarbonate administration for metabolic acidosis in the intensive care unit: a target-trial emulation. Intensive Care Med. 2025;51(4):455-466.
    67. SODa-BIC Investigators. Protocol for the Sodium Bicarbonate Administration Trial in Critically Ill Patients with Metabolic Acidosis (SODa-BIC). Crit Care Resusc. 2025;27(1):22-30.

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.